OBJECTIVE: This study analyzed selection criteria, clinical outcome, a
nd tumor growth rates in patients with acoustic neuromas in whom the i
nitial management strategy was observation. METHODS: A retrospective r
eview of patients with conservatively managed unilateral acoustic neur
omas was conducted. Minimum follow-up was 6 months. Patients with neur
ofibromatosis Type II were excluded. Differences in tumor growth rates
were analyzed by use of the Wilcoxon rank sum test. RESULTS: Sixty-ei
ght patients (31 men and 37 women) with a mean age of 67.1 years were
followed for an average of 3.4 years after diagnosis. The reasons for
a trial of observation included advanced age (55%), patient preference
(21%), minimal symptoms (9%), poor general medical condition (7%), as
ymptomatic tumor (4%), and tumor in the only hearing ear (4%). Fifty-e
ight patients (85%) were successfully managed with of observation alon
e. Ten patients (15%) ultimately required treatment (nine received mic
rosurgical treatment and one patient underwent radiosurgical intervent
ion) at a mean time interval of 4.0 years after diagnosis. Forty-eight
tumors (71%) showed no growth and 20 (29%) enlarged during the study
period. The mean tumor growth rate at the 1-year follow-up was signifi
cantly higher in the group requiring treatment (3.0 mm) than in the gr
oup not requiring treatment (0.36 mm) (P < 0.0001). Thus, the tumor gr
owth rate at the 1-year follow-up was a strong predictor of the eventu
al need for treatment. CONCLUSION: Observation is a reasonable managem
ent strategy in carefully selected patients with acoustic neuromas. Di
ligent follow-up with serial magnetic resonance imaging is recommended
, because some tumors will enlarge to the point at which active treatm
ent is required.